IL-13 regulates vascular cell adhesion molecule-1 expression in human osteoblasts

Journal of Cellular Biochemistry

Volumn 89, Issue 2, 2003, Pages 213-219

  Rifas, Leonard ^a,b   Cheng, Su Li ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cell communication; Cytokines; Osteoclastogenesis; Rheumatoid arthritis; T cells

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 13; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MYELOMA CELL; NORTHERN BLOTTING; OSTEOBLAST; OSTEOCLAST; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; OSTEOBLASTS; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0038034411     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10531     Document Type: Article

References (28)

1. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154:799-803.
2. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Paynton BV, Jee WS, Hendy GN, Epstein S. 1995. Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat. J Bone Miner Res 10:1556-1565.
3. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Romero DF, Jee WS, Epstein S. 1996. T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278-2285.
4. Carter RA, Wicks IP. 2001. Vascular cell adhesion molecule 1 (CD106): A multifaceted regulator of joint inflammation. Arthritis Rheum 44:985-994.
5. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
6. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577-584.
7. Feuerbach D, Feyen JH. 1997. Expression of the cell-adhesion molecule VCAM-1 by stromal cells is necessary for osteoclastogenesis. FEBS Lett 402:21-24.
8. Frost A, Jonsson KB, Brandstrom H, Ohlsson C, Ljunghall S, Ljunggren O. 1998. Interleukin-13 inhibits cell proliferation and stimulates interleukin-6 formation in isolated human osteoblasts. J Clin Endocrinol Metab 83:3285-3289.
9. Frost A, Jonsson KB, Brandstrom H, Ljunghall S, Nilsson O, Ljunggren O. 2001. Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: Evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. Bone 28:268-274.
10. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.
11. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. 1990. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144:4226-4230.
12. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliot R, Colombero A, Elliot G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian Y-X, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
13. Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T. 2000. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 96:1953-1960.
14. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211.
15. Quesniaux VF. 1993. Immunosuppressants: Tools to investigate the physiological role of cytokines. Bioessays 15:731-739.
16. Rifas L, Avioli LV. 1999. A novel T cell cytokine stimulates interleukin-6 in human osteoblastic cells. J Bone Miner Res 14:1096-1103.
17. Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus HG. 1994. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: Differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134:213-221.
18. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV. 1995. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 136:4056-4067.
19. Rifas L, Arackal S, Weitzmann MN. 2003. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem 88:650-659.
20. Roodman GD. 1992. Interleukin-6: An osteotropic factor? J Bone Miner Res 7:475-478.
21. Scopes J, Massey HM, Ebrahim H, Horton MA, Flanagan AM. 2001. Interleukin-4 and interleukin-13: Bidirectional effects on human osteoclast formation. Bone 29:203-208.
22. Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F. 1994. Regulation of endothelial and mesothelial cell function by interleukin-13: Selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84:1913-1921.
23. Tanaka Y, Morimoto I, Nakano Y, Okada Y, Hirota S, Nomura S, Nakamura T, Eto S. 1995. Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J Bone Miner Res 10:1462-1469.
24. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P. 1996. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26:549-555.
25. van der Pouw Kraan TC, Boeije LC, Troon JT, Rutschmann SK, Wijdenes J, Aarden LA. 1996. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 156:1818-1823.
26. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R. 2001. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328-337.
27. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
28. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. 2002. Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 22:146-167.